Publikasi Dosen
PROFILE OF PULMONARY TUBERCULOSIS TREATMENT IN INPATIENTS WITH COVID-19 HISTORY STATUS AT PASAR MINGGU REGIONAL GENERAL HOSPITAL
Pulmonary tuberculosis (TB) is caused by Mycobacterium tuberculosis, which attacks the respiratory system. In the midst of the soaring Covid-19 virus outbreak, TB patients are patients who should be more vigilant about the outbreak. GTN (Global Tuberculosis Network) describes that out of 49 patients with TB status, about 26 patients suffering from TB were then exposed to Covid-19. The purpose is to determine profile of pulmonary tuberculosis treatment in inpatients with Covid-19 history status at Pasar Minggu Regional General Hospital during the May 2020–May 2021 period. The method of the study is quantitative descriptive analysis with a retrospective method, which is to take primary data from the patient's medical record. The result shows that the total number of patients was 22. The most common gender was male at 12 (54.55%). The average patient weight is 38-54 kg, with a number of 11 people (50%). The most common type of patient is a new patient with 10 people (45.45%). The most treated category was Category II, with 12 people (54.54%). The three-tablet pattern is the most commonly prescribed.4KDT and three tablets. 2KDT and four tablets. 4KDT plus four tablets. 2KDT has the same proportion of 4 prescribing (18.18%). The most prescribed KDT pattern of ketogori 2 is 3 tablets 4KDT + 750mg streptomycin inj & 3 tablets 2KDT + 3 tablets ethambutol, as much as 9 prescriptions (40.90%). Medications for Covid-19 patients are most commonly prescribed in conjunction with
tuberculosis drugs, namely vitamins and minerals, as many as 56 drug items (42.42%).
Tidak tersedia versi lain